a. This is a case of incomplete dominance. ![]() |
||
b. This is a case of dominant inheritance. ![]() |
||
c. This is a case of recessive inheritance. ![]() |
||
d. This is a case of Mendelian inheritance. ![]() |
a. The husband is right; he cannot be the father. The father of the child must have AB or B blood type. ![]() |
||
b. The husband is right; he cannot be the father. The father of the child must have O blood type. ![]() |
||
c. The husband is wrong. He can be the father, if his genotype is AO. ![]() |
||
d. The husband is wrong. He can be the father, if his genotype is AA. ![]() |
a. 1 in 16 ![]() |
||
b. 2 in 16 ![]() |
||
c. 3 in 16 ![]() |
||
d. 9 in 16 ![]() |
a. Yes, because Jane has Bb genotype and Joe has BB genotype, where B stands for the dominant brown eye and b stands for the recessive blue eye. There is a 50% chance that their children would be blue-eyed and have Bb or BB genotype. ![]() |
||
b. Yes, because Jane has Bb genotype and Joe has BB genotype, where B stands for the dominant brown eye and b stands for the recessive blue eye. All of their children should be blue-eyed and have Bb or BB genotype. ![]() |
||
c. No, because Jane has BB genotype and Joe has Bb genotype, where B stands for the dominant brown eye and b stands for the recessive blue eye. There is a 50% chance that their children would be brown-eyed and have Bb or BB genotype. ![]() |
||
d. No, because Jane has Bb genotype and Joe has BB genotype, where B stands for the dominant brown eye and b stands for the recessive blue eye. All of their children should be brown-eyed and have Bb or BB genotype. ![]() |
a. Conventional PCR ![]() |
||
b. RT-PCR ![]() |
||
c. Real-time RT-PCR ![]() |
||
d. Subtractive hybridization ![]() |
a. 4 ![]() |
||
b. 8 ![]() |
||
c. 16 ![]() |
||
d. 32 ![]() |
a. Ribozymes ![]() |
||
b. RNAi ![]() |
||
c. MicroRNA ![]() |
||
d. Riboswithes ![]() |
a. In the cgfp gene, the codon usage is C. reinhardtii-conform. ![]() |
||
b. The cgfp gene is expressing a different GFP protein sequence. ![]() |
||
c. The cgfp gene is expressing a GFP protein with different color. ![]() |
||
d. In the cgfp gene, there are fewer introns. ![]() |
a. Conventional PCR ![]() |
||
b. RT-PCR ![]() |
||
c. Real-time RT-PCR ![]() |
||
d. Subtractive hybridization. ![]() |
a. Radioactive ![]() |
||
b. Fluorescent ![]() |
||
c. Silver-enhanced gold ![]() |
||
d. Photoenhanced ![]() |
a. Junk DNA ![]() |
||
b. Pseudogene ![]() |
||
c. Long repeat ![]() |
||
d. Non-coding region ![]() |
a. Overlapping chromosome fragments are sequenced continuously without leaving any gap behind. ![]() |
||
b. Both ends of random chromosome fragments are sequenced and then the fragments are assembled using computer programs. ![]() |
||
c. Scaffolds are sequenced and contigs are built from scaffolds. ![]() |
||
d. Chromosomes are sequenced between FISH-stained locations and assembled according to these known cytological markers. ![]() |
a. Divergence, common ancestor ![]() |
||
b. Distance, common ancestor ![]() |
||
c. Divergence, distance ![]() |
||
d. Distance, adaptation ![]() |
a. Higher ![]() |
||
b. Lower ![]() |
||
c. Unchanged ![]() |
||
d. Negligible ![]() |
a. Genes which are not expressed differentially in tumor and normal cells. ![]() |
||
b. Genes which are overexpressed in normal cells. ![]() |
||
c. Genes which are overexpressed in tumor cells. ![]() |
||
d. Promoter sequences which are particularly active in tumor cells. ![]() |
a. RNA—protein interaction prediction. ![]() |
||
b. Gene prediction. ![]() |
||
c. Open reading frame prediction. ![]() |
||
d. Nucleic acid sequence translation to protein sequence. ![]() |
a. Euchromatin ![]() |
||
b. Heterochromatin ![]() |
||
c. Telomere ![]() |
||
d. Centromere ![]() |
a. Short known DNA sequences can be synthesized chemically directly on chip. ![]() |
||
b. All genes of an organism can be bound in microarrays, and these arrays can be used in differential gene expression studies. ![]() |
||
c. Microarrays made from the genome of an organism are typically probed with a whole genomic DNA probe made from the same organism. ![]() |
||
d. Fluorescent probes can be used to identify genes on microarrays. ![]() |
a. 10 and 6 ![]() |
||
b. 11 and 6 ![]() |
||
c. 14 and 6 ![]() |
||
d. 11 and 10 ![]() |
a. DNA extraction, restriction enzymes, and Southern blot ![]() |
||
b. DNA extraction, PCR, and Southern blot ![]() |
||
c. DNA extraction, restriction enzymes, and Western blot ![]() |
||
d. DNA extraction, PCR, and Western blot ![]() |
a. Overlapping chromosome fragments are sequenced continuously without leaving any gap behind. ![]() |
||
b. Both ends of random chromosome fragments are sequenced and then the fragments are assembled using computer programs. ![]() |
||
c. Scaffolds are sequenced and contigs are built from scaffolds. ![]() |
||
d. Chromosomes are sequenced between FISH-stained locations and assembled according to these known cytological markers. ![]() |
a. A single nucleotide change. ![]() |
||
b. A single codon change. ![]() |
||
c. A single amino acid change. ![]() |
||
d. A small genetic change. ![]() |
a. The ratio of poly-Q and poly-A ![]() |
||
b. The total length of poly-Q and poly-A ![]() |
||
c. Only the length of poly-Q ![]() |
||
d. Only the length of poly-A ![]() |
a. Proteomics ![]() |
||
b. Metagenomics ![]() |
||
c. Metabolomics ![]() |
||
d. Proteomics ![]() |
a. ABC ![]() |
||
b. ACB ![]() |
||
c. CAB ![]() |
||
d. CBA ![]() |
a. Metagenomics ![]() |
||
b. Envirogenomics ![]() |
||
c. Nature genomics ![]() |
||
d. Microbiomics ![]() |
a. Genetic map. ![]() |
||
b. Physical map ![]() |
||
c. Open reading frame ![]() |
||
d. Gene sequence ![]() |
a. Model organisms have genes similar to human genes. ![]() |
||
b. Model organisms are mainly used to highlight the differences between animals and humans. ![]() |
||
c. Model organisms can attract animal-loving students to genomics. ![]() |
||
d. A focus on the differences contributes to our understanding of genetic inheritance. ![]() |
a. Proteomics ![]() |
||
b. Metagenomics ![]() |
||
c. Metabolomics ![]() |
||
d. Proteomics ![]() |
a. Crossing over of the sister chromatids during meiosis I. ![]() |
||
b. Crossing over of the non-sister chromatids during meiosis I. ![]() |
||
c. Crossing over of the sister chromatids during meiosis II. ![]() |
||
d. Crossing over of the non-sister chromatids during meiosis II. ![]() |
a. Design gene therapy ![]() |
||
b. Clone animals ![]() |
||
c. Combine functional units of different proteins ![]() |
||
d. Generate novel cell types ![]() |
a. Cell differentiation ![]() |
||
b. Meiosis ![]() |
||
c. The locus of gene insertion ![]() |
||
d. Codon preference ![]() |
a. Transposable elements ![]() |
||
b. Proteases ![]() |
||
c. Epigenetic changes ![]() |
||
d. DNA methylation ![]() |
a. Lysosomes ![]() |
||
b. Extracellular space ![]() |
||
c. Nucleus ![]() |
||
d. Golgi ![]() |
a. Affinity chromatography and immunoprecipitation ![]() |
||
b. Exclusion chromatography and immunoprecipitation ![]() |
||
c. Western blot and exclusion chromatography ![]() |
||
d. Western blot and Northern blot ![]() |
a. Higher temperatures utilizing the increased Brownian motion ![]() |
||
b. The presence of complementing surfaces ![]() |
||
c. Processing enzymes which seal the protein in the right conformation with chemical bonds ![]() |
||
d. Chaperones that prevent premature aggregation of hydrophobic regions ![]() |
a. Dideoxy sequencing ![]() |
||
b. Edman degradation ![]() |
||
c. MALDI ![]() |
||
d. MS-MS ![]() |
a. Dideoxy sequencing ![]() |
||
b. Edman degradation ![]() |
||
c. MALDI ![]() |
||
d. MS-MS ![]() |
a. Can be modified posttranslationally ![]() |
||
b. Cannot be modified posttranslationally ![]() |
||
c. Are spontaneously secreted ![]() |
||
d. Are synthesized on ribosomes ![]() |
a. A separate surface from the DNA ![]() |
||
b. The surface as the DNA ![]() |
||
c. An antibody capture array ![]() |
||
d. A functional array ![]() |
a. Greatly ![]() |
||
b. Hardly ![]() |
||
c. Never ![]() |
||
d. Temporarily ![]() |
a. Simultaneously, enhancers ![]() |
||
b. Simultaneously, operons ![]() |
||
c. Consecutively, enhancers ![]() |
||
d. Consecutively, operons ![]() |
a. Eastern blot ![]() |
||
b. Northern blot ![]() |
||
c. Southern blot ![]() |
||
d. Western blot ![]() |
a. Size ![]() |
||
b. Shape ![]() |
||
c. Electric charge ![]() |
||
d. Polarity ![]() |
a. Burst ![]() |
||
b. Stay intact ![]() |
||
c. Shrink ![]() |
||
d. Divide ![]() |
a. Genomes ![]() |
||
b. Viruses ![]() |
||
c. Plasmids ![]() |
||
d. Vectors ![]() |
a. Reporter genes ![]() |
||
b. Selection genes ![]() |
||
c. Detection genes ![]() |
||
d. Promoters ![]() |
a. Knock-out ![]() |
||
b. Random insertion ![]() |
||
c. Mutated ![]() |
||
d. Inverted ![]() |
a. Providing extracellular matrix for ![]() |
||
b. Adding Ti plasmid to the growth medium of ![]() |
||
c. Inducing de-differentiation of ![]() |
||
d. Inducing viral gene transfer of ![]() |
a. Zinc ![]() |
||
b. Iron ![]() |
||
c. Selenium ![]() |
||
d. flavin ![]() |
a. Somatic ![]() |
||
b. Multipotent stem ![]() |
||
c. Totipotent stem ![]() |
||
d. Germ ![]() |
a. Only recessive homozygous ![]() |
||
b. Only homozygous traits ![]() |
||
c. Only dominant genes ![]() |
||
d. A desired combination of recessive and dominant genes ![]() |
a. Hair shaft ![]() |
||
b. Saliva ![]() |
||
c. Blood ![]() |
||
d. Milk ![]() |
a. Genetic mosaics ![]() |
||
b. Hybridomas ![]() |
||
c. Genetic mixtures ![]() |
||
d. Hybrids ![]() |
a. Somatic cell nuclear transfer ![]() |
||
b. Germ line nuclear transfer ![]() |
||
c. In vitro fertilization ![]() |
||
d. Recombineering ![]() |
a. Her shorter than average ![]() |
||
b. Her longer than average ![]() |
||
c. The absence of the ![]() |
||
d. The branching ![]() |
a. Forward genetic ![]() |
||
b. Reverse genetic ![]() |
||
c. Transgenic ![]() |
||
d. Mutagenic ![]() |
a. Substantial homologous ![]() |
||
b. Minimal homologous ![]() |
||
c. Substantial heterologous ![]() |
||
d. Minimal heterologous ![]() |
a. Site specific insertion; neutralization of position effects ![]() |
||
b. Neutralization of position effects; site specific insertion ![]() |
||
c. P element insertion; recombinases and integrases ![]() |
||
d. Recombinases and integrases; P element insertion. ![]() |
a. offer protection against ![]() |
||
b. enhance ![]() |
||
c. attenuate insect bites delivering ![]() |
||
d. intensify ![]() |
a. Preimplantation genetic diagnosis ![]() |
||
b. Postimplantation genetic diagnosis ![]() |
||
c. Prefertilization genetic diagnosis ![]() |
||
d. Genetic counseling ![]() |
a. Blue fluorescent protein ![]() |
||
b. Green fluorescent protein ![]() |
||
c. Red fluorescent protein ![]() |
||
d. Yellow fluorescent protein ![]() |
a. Insertion position ![]() |
||
b. Activity ![]() |
||
c. High copy number ![]() |
||
d. Inactivity ![]() |
a. DNA methylation ![]() |
||
b. Chromosomal rearrangement ![]() |
||
c. Missense mutation ![]() |
||
d. Chromosomal inversion ![]() |
a. 16 % ![]() |
||
b. 30% ![]() |
||
c. 40% ![]() |
||
d. 90% ![]() |
a. Stem cells; virus transformed cells ![]() |
||
b. Blood cells; virus transformed cells ![]() |
||
c. Stem cells; mutated cells ![]() |
||
d. Blood cells; mutated cells ![]() |
a. Zinc-finger nuclease ![]() |
||
b. Protease ![]() |
||
c. Antibody ![]() |
||
d. Lipase ![]() |
a. Every; every ![]() |
||
b. Every; a tumor ![]() |
||
c. A tumor, a tumor ![]() |
||
d. A tumor, every ![]() |
a. 0% ![]() |
||
b. 25% ![]() |
||
c. 50% ![]() |
||
d. 75% ![]() |
a. Point; malaria parasite ![]() |
||
b. Nonsense; malaria parasite ![]() |
||
c. Point; papillomavirus ![]() |
||
d. Nonsense; papillomavirus ![]() |
a. Gene gun, gold ![]() |
||
b. Gene gun, iron ![]() |
||
c. Particle gun, gold ![]() |
||
d. Particle gun, iron ![]() |
a. Turner ![]() |
||
b. Klinefelter ![]() |
||
c. Down ![]() |
||
d. Edwards ![]() |
a. Not wear off as we age; can ![]() |
||
b. Wear off as we age; can ![]() |
||
c. Not wear off as we age; cannot ![]() |
||
d. Wear off as we age; cannot ![]() |
a. Noncoding chromosomal regions ![]() |
||
b. Coding chromosomal regions ![]() |
||
c. One chromosome ![]() |
||
d. Sex chromosomes ![]() |
a. Simplicity of ![]() |
||
b. Instantaneous result of ![]() |
||
c. Statistical strength linked to ![]() |
||
d. Variety of available protocols for ![]() |
a. If a Y-typing is performed and shows that Mr. X’s Y chromosome is identical to the Y chromosome of Ms. Y’s son, then Mr. X must be the father. ![]() |
||
b. If a Y-typing is performed and shows that Mr. X’s Y chromosome is identical to the Y chromosome of Ms. Y’s son, then Mr. X or another man of his paternal line must be the father. ![]() |
||
c. If forensic DNA-typing is performed utilizing the standard 13 STR regions and shows that Mr. Y’s son has one-one allele of Mr. X’s each analyzed STR allele pair, then Mr. X must be the father. ![]() |
||
d. DNA fingerprinting cannot prove that Mr. X is the father of Ms. Y’s son. But if they are father and son, their friction ridge patterns will be identical on all of their fingers. ![]() |
a. Fermentation ![]() |
||
b. Extraction ![]() |
||
c. Bioaccumulation ![]() |
||
d. Bioamplification ![]() |
a. Single-species; multi-species ![]() |
||
b. Multi-species; single-species ![]() |
||
c. Single-layer; multi-layer ![]() |
||
d. Multi-layer; single-layer ![]() |
a. Biochemical reactions ![]() |
||
b. Microbes ![]() |
||
c. Plants ![]() |
||
d. Animals ![]() |
a. As carbonate-based concrete ![]() |
||
b. As Roman-style ![]() |
||
c. As concrete ![]() |
||
d. Underground ![]() |
a. Fermentation ![]() |
||
b. Extraction ![]() |
||
c. Bioaccumulation ![]() |
||
d. Bioamplification ![]() |
a. Simple; longer ![]() |
||
b. Technologically challenging; shorter ![]() |
||
c. Simple; shorter ![]() |
||
d. Technologically challenging; longer ![]() |
a. Bacteria ![]() |
||
b. Plants ![]() |
||
c. Birds ![]() |
||
d. Fishes ![]() |
a. Simple; longer ![]() |
||
b. Technologically challenging; shorter ![]() |
||
c. Simple; shorter ![]() |
||
d. Technologically challenging; longer ![]() |
a. Soluble in fat. ![]() |
||
b. Hydrophilic. ![]() |
||
c. Stable. ![]() |
||
d. Biologically active. ![]() |
a. Bacteria ![]() |
||
b. Plant ![]() |
||
c. Bird ![]() |
||
d. Fish ![]() |
a. Four ![]() |
||
b. Five ![]() |
||
c. Six ![]() |
||
d. Seven ![]() |
a. Chemostat ![]() |
||
b. Traditional liquid culture ![]() |
||
c. Semisolid culture ![]() |
||
d. Subculture ![]() |
a. Bioleaching ![]() |
||
b. Bioremediation ![]() |
||
c. In situ ![]() |
||
d. Biofilm ![]() |
a. Hydrogenases ![]() |
||
b. Hydrogen ion pumps ![]() |
||
c. Electron transport chain ![]() |
||
d. ATP ![]() |
a. isobutanol ![]() |
||
b. glucose ![]() |
||
c. penicillin ![]() |
||
d. hydrogen ![]() |
a. Just a fancy name for a multivitamin complex ![]() |
||
b. An antigen engineered into a plant we eat ![]() |
||
c. An attenuated oral vaccine, like the Sabin drops ![]() |
||
d. An antibody engineered into the plant we eat ![]() |
a. Saccharopolyspora erythraea ![]() |
||
b. Saccharomyces cerevisiae ![]() |
||
c. Streptomyces parvullus ![]() |
||
d. Clostridium cellulolyticum ![]() |
a. Lead to gene doping ![]() |
||
b. Initiate intensive wellness activities ![]() |
||
c. Can be easily accepted in sports ![]() |
||
d. Might to be legalized soon ![]() |
a. Genetic counseling ![]() |
||
b. Pharmacogenomics ![]() |
||
c. Pharmacokinetics ![]() |
||
d. Pharmacology ![]() |
a. Protect against the body’s immune response ![]() |
||
b. Bring another alternative to the market ![]() |
||
c. Follow these particles with body scanning ![]() |
||
d. Determine how fat particles leaves the body ![]() |
a. to build organs that are not rejected ![]() |
||
b. for future applications ![]() |
||
c. for donation ![]() |
||
d. in cloning ![]() |
a. Embryonic stem cells ![]() |
||
b. Somatic stem cells ![]() |
||
c. Adult stem cells ![]() |
||
d. Multipotent stem cells ![]() |
a. Mycoplasma Laboratorium ![]() |
||
b. Agrobacterium tumefaciens ![]() |
||
c. Escherichia coli ![]() |
||
d. Saccharomyces cerevisiae ![]() |
a. Radioimmunotherapy ![]() |
||
b. Radiotoxins ![]() |
||
c. Radiation therapy ![]() |
||
d. Chemotherapy ![]() |